Therefore, forced NOX4 overexpression could mitigate the development of NASH and fibrosis otherwise associated with the decline in Nox4 expression in mice fed a NASH- and fibrosis-promoting CD-HFD. This evidence concerns the gene NOX4 and metabolic dysfunction-associated steatohepatitis.